SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Florence Griffith Joyner Synthetic CCD — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientFlorence Griffith Joyner
Date of birth1959-12-21
IdentifiersMRN HR-ML033-SYN-TD; SSN (made up) 000-33-2648
Document date2026-11-01
AuthorCeleste Vanterpool, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Two and a half weeks after a generalized seizure on a flight: history, examination, laboratory screen, EEG and MRI ordered, driving and safety advice, and neurology (epilepsy) review booked. Concerns: A seizure on a flight two and a half weeks ago, after which she was kept in hospital overnight; she remembers nothing of the seizure itself and wants to understand what happened; She wants to know why it happened and how to stop it happening again, and whether she can keep training, driving and flying; She wants the details kept private. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Levetiracetam 500 mg oral tablet, one tablet by mouth twice dailyOne tablet twice dailyOral route1996-05-05activeS
Folic acid 0.4 mg oral tablet, one tablet dailyOne tablet dailyOral route1996-05-05activeS
Acetaminophen 500 mg oral tablet, two tablets by mouth every 6 hours as needed for pain after surgery, no more than 3 g a dayTwo tablets every 6 hours as neededOral route1996-06-16 to 1996-06-30completedS

Procedures

ProcedureDatesStatusEvidence
Routine EEG with sleep deprivation the night before, awake and asleep, with hyperventilation and photic stimulation: intermittent left frontal sharp waves and focal slowing (maximum F7 and Fp1); no generalized discharges; no seizure recorded1996-04-24 to 1996-04-24completedS
MRI of the brain, epilepsy protocol, with susceptibility-weighted imaging and gadolinium: a 1.4 cm mulberry-like lesion in the left orbitofrontal cortex with mixed signal and a complete hemosiderin rim (cavernous malformation, Zabramski type II), an adjacent developmental venous anomaly, no other lesion on susceptibility-weighted imaging, and no acute hemorrhage or edema1996-04-28 to 1996-04-28completedS
Advance care planning conversation, about 15 minutes1996-08-25 to 1996-08-25completedS
Left frontal craniotomy with neuronavigation for complete excision of the orbitofrontal cavernous malformation with the surrounding hemosiderin-stained brain, sparing the developmental venous anomaly; no complications; home on the third day. Pathology: cavernous malformation (closely packed, thin-walled vascular channels without intervening brain, with old hemorrhage and hemosiderin in the surrounding gliotic tissue)1996-06-16 to 1996-06-16completedS
MRI of the brain the day after surgery: complete resection of the cavernous malformation and the hemosiderin rim; expected postoperative changes; developmental venous anomaly preserved; no hemorrhage or infarct1996-06-17 to 1996-06-17completedS

Immunizations

DateVaccineStatusEvidence
1996-08-25Tetanus, diphtheria, and acellular pertussis vaccine (Tdap)completedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
1990 to 1994Treated for seizures in 1990, 1993 and 1994, as reported from the coroner's records after her death; details not publicD (CLM-0006)
April 1996Seizure on a flight in April 1996; discharged from hospital the next day; the family asked that no other details be releasedD (CLM-0005)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Health Concerns

ConcernStatusEvidence
A seizure on a flight two and a half weeks ago, after which she was kept in hospital overnight; she remembers nothing of the seizure itself and wants to understand what happenedactiveS
She wants to know why it happened and how to stop it happening again, and whether she can keep training, driving and flyingactiveS
She wants the details kept privateactiveS

Assessment

Most recent measures: Hemoglobin [Mass/volume] in Blood 13.4 on 1996-04-22; Leukocytes [#/volume] in Blood by Automated count 6.1 on 1996-04-22; Platelets [#/volume] in Blood by Automated count 238 on 1996-04-22; Sodium [Moles/volume] in Serum or Plasma 140 on 1996-04-22; Potassium [Moles/volume] in Serum or Plasma 4.1 on 1996-04-22; Creatinine [Mass/volume] in Serum or Plasma 0.92 on 1996-04-22; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1991)/1.73 sq M 83 on 1996-04-22; Glucose [Mass/volume] in Serum or Plasma 86 on 1996-04-22; Calcium [Mass/volume] in Serum or Plasma 9.6 on 1996-04-22; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 17 on 1996-04-22; Magnesium [Mass/volume] in Serum or Plasma 2 on 1996-04-22; Creatine kinase [Enzymatic activity/volume] in Serum or Plasma 168 on 1996-04-22; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 1996-08-25; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 6 on 1996-04-22; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 2 on 1996-10-20 [S]

Strengths and supports: Married, with a young child; household members are not named and have no role in this record. Supports: her household, her training community, and the young athletes she works with [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Generalized tonic-clonic seizure on a flight two and a half weeks ago, in a 36-year-old woman who was observed overnight in hospital elsewhere and has had treatment for seizures in the past, records requested; no antiseizure medication now; normal examination today. Evaluated as a new seizure: EEG and MRI of the brain with susceptibility-weighted imaging ordered, neurology (epilepsy) review booked, and no drivingresolvedconfirmed R56.9S — Synthetic presenting problem anchored to her publicly reported seizure on a flight; superseded by the diagnosis at the epilepsy consultation.
Focal epilepsy with structural cause: focal to bilateral tonic-clonic seizure from a left orbitofrontal cavernous malformation, with left frontal epileptiform discharges on EEG; epilepsy under the ILAE 1984 practical definition (an unprovoked seizure with a recurrence risk above 60% from an epileptogenic lesion, and earlier seizures by history); synthetic modern detail linked to her publicly reported seizures and the coroner's findingactiveconfirmed G40.209S — Synthetic seizure type, EEG and classification; the seizures and the cavernous angioma of the left orbital frontal cerebrum are documented (D).
Solitary cerebral cavernous malformation, 1.4 cm, left orbitofrontal cortex, with a hemosiderin rim and an adjacent developmental venous anomaly, no other lesion on susceptibility-weighted imaging (sporadic pattern); no acute hemorrhageresolvedconfirmed Q28.3S — Synthetic imaging detail; the coroner reported a congenital cavernous angioma of the left orbital frontal cerebrum (D).

Results

DateMeasureValueUnitReference rangeFlagProvenance
1996-04-22Hemoglobin [Mass/volume] in Blood13.4g/dL12-15.5 g/dLNormalS
1996-04-22Leukocytes [#/volume] in Blood by Automated count6.110*3/uL4-11 10*3/uLNormalS
1996-04-22Platelets [#/volume] in Blood by Automated count23810*3/uL150-400 10*3/uLNormalS
1996-04-22Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
1996-04-22Potassium [Moles/volume] in Serum or Plasma4.1mmol/L3.5-5.1 mmol/LNormalS
1996-04-22Creatinine [Mass/volume] in Serum or Plasma0.92mg/dL0.59-1.04 mg/dLNormalS
1996-04-22Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1991)/1.73 sq M83mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1996-04-22Glucose [Mass/volume] in Serum or Plasma86mg/dL70-99 mg/dLNormalS
1996-04-22Calcium [Mass/volume] in Serum or Plasma9.6mg/dL8.6-10.3 mg/dLNormalS
1996-04-22Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma17U/L7-35 U/LNormalS
1996-04-22Magnesium [Mass/volume] in Serum or Plasma2mg/dL1.7-2.2 mg/dLNormalS
1996-04-22Creatine kinase [Enzymatic activity/volume] in Serum or Plasma168U/L26-192 U/LNormalS
1996-04-22Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
1996-04-22Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]6{score}S
1996-05-05Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]3{score}S
1996-05-27Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]6{score}S
1996-07-21Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S
1996-10-20Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]2{score}S
1996-08-25Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
1996-04-22Body height170cmS
1996-04-22Body weight61kgS
1996-04-22Body mass index (BMI) [Ratio]21.1kg/m2S
1996-04-22Systolic blood pressure112mm[Hg]S
1996-04-22Diastolic blood pressure70mm[Hg]S
1996-04-22Heart rate56/minS
1996-04-22Respiratory rate14/minS
1996-04-22Body temperature36.7CelS
1996-04-22Oxygen saturation in Arterial blood by Pulse oximetry99%S
1996-05-05Body height170cmS
1996-05-05Body weight61.2kgS
1996-05-05Body mass index (BMI) [Ratio]21.2kg/m2S
1996-05-05Systolic blood pressure110mm[Hg]S
1996-05-05Diastolic blood pressure68mm[Hg]S
1996-05-05Heart rate58/minS
1996-05-05Respiratory rate14/minS
1996-05-05Body temperature36.6CelS
1996-05-05Oxygen saturation in Arterial blood by Pulse oximetry99%S
1996-05-27Body height170cmS
1996-05-27Body weight60.8kgS
1996-05-27Body mass index (BMI) [Ratio]21kg/m2S
1996-05-27Systolic blood pressure114mm[Hg]S
1996-05-27Diastolic blood pressure72mm[Hg]S
1996-05-27Heart rate60/minS
1996-05-27Respiratory rate14/minS
1996-05-27Body temperature36.7CelS
1996-05-27Oxygen saturation in Arterial blood by Pulse oximetry99%S
1996-07-21Body height170cmS
1996-07-21Body weight60.1kgS
1996-07-21Body mass index (BMI) [Ratio]20.8kg/m2S
1996-07-21Systolic blood pressure108mm[Hg]S
1996-07-21Diastolic blood pressure68mm[Hg]S
1996-07-21Heart rate62/minS
1996-07-21Respiratory rate14/minS
1996-07-21Body temperature36.6CelS
1996-07-21Oxygen saturation in Arterial blood by Pulse oximetry99%S
1996-10-20Body height170cmS
1996-10-20Body weight60.9kgS
1996-10-20Body mass index (BMI) [Ratio]21.1kg/m2S
1996-10-20Systolic blood pressure110mm[Hg]S
1996-10-20Diastolic blood pressure70mm[Hg]S
1996-10-20Heart rate54/minS
1996-10-20Respiratory rate14/minS
1996-10-20Body temperature36.6CelS
1996-10-20Oxygen saturation in Arterial blood by Pulse oximetry99%S
1996-08-25Body height170cmS
1996-08-25Body weight60.6kgS
1996-08-25Body mass index (BMI) [Ratio]21kg/m2S
1996-08-25Systolic blood pressure110mm[Hg]S
1996-08-25Diastolic blood pressure70mm[Hg]S
1996-08-25Heart rate56/minS
1996-08-25Respiratory rate14/minS
1996-08-25Body temperature36.6CelS
1996-08-25Oxygen saturation in Arterial blood by Pulse oximetry99%S

Encounters

DatePurposeStatusProvenance
1996-04-22Two and a half weeks after a generalized seizure on a flight: history, examination, laboratory screen, EEG and MRI ordered, driving and safety advice, and neurology (epilepsy) review bookedfinishedS
1996-05-05EEG and MRI results: focal epilepsy from a left orbitofrontal cavernous malformation; epilepsy consultation, levetiracetam with folic acid, and neurosurgical opinion requestedfinishedS
1996-05-27Three weeks on levetiracetam: mood and side effects, the neurosurgical opinion and surgery date, SUDEP and safety counselingfinishedS
1996-07-21Five weeks after lesionectomy: recovery, seizure control, return to trainingfinishedS
1996-10-20Six months after the seizure: seizure freedom, driving review, training, and the long-term planfinishedS
1996-08-25Periodic adult preventive visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Neurology (epilepsy) consultation within two weeks to interpret the EEG and MRI, decide whether this is epilepsy, and advise on antiseizure medication, surgery and safetycompletedGL-AAN-FIRSTSZ-2015, GL-ILAE-DEF-2014S
Evaluation of a seizure in an adult: history from her and witnesses' accounts, examination, blood count, electrolytes, glucose, calcium, magnesium, kidney and liver tests and creatine kinase, a pregnancy test, a sleep-deprived EEG, and MRI of the brain with an epilepsy protocol including susceptibility-weighted imaging; records of her earlier seizure care requestedcompletedGL-AAN-FIRSTSZ-2015S
Safety from today: no driving, and the report of a disorder characterized by lapses of consciousness that California requires of physicians, explained to her before it is sent; no swimming alone or bathing in a tub, showers instead; no heights or working alone near water; seizure first aid and a written seizure action plan, calling emergency services for a seizure lasting five minutes or morecompletedGL-CA-DMV-2024, GL-AAN-FIRSTSZ-2015S
Levetiracetam 500 mg twice daily, chosen for a woman who could become pregnant (low risk of birth defects, no interaction with hormonal contraception), with folic acid 0.4 mg daily; valproate avoided because of its risk of major malformations and lower intelligence in children exposed in pregnancy; contraception and pregnancy planning discussed; mood and irritability checked with the PHQ-9 at each visitcompletedGL-AAN-TERATO-2024, GL-AAN-FIRSTSZ-2015, GL-ILAE-DEF-2014S
Neurosurgical evaluation of the epileptogenic cavernous malformation, with lesionectomy including the hemosiderin rim if she chooses itcompletedGL-CCM-2017S
SUDEP counseling as the AAN/AES guideline requires: what it is, that tonic-clonic seizures are the main risk, and how to lower it (take every dose, keep regular sleep, avoid alcohol excess, aim for no tonic-clonic seizures); nocturnal supervision or a seizure detection watchcompletedGL-AAN-SUDEP-2017, GL-ILAE-DETECT-2021S
Graded return to training after surgery: walking and stationary cycling from two weeks, running from four to six weeks, sprint sessions from six to eight weeks, full training by three to four months, with no heavy lifting until the craniotomy has healed; swimming only with a companion who knows seizure first aidcompletedGL-CCM-2017, GL-AAN-FIRSTSZ-2015S
Long term: levetiracetam for at least two years after surgery, then a shared decision about tapering with an EEG; driving when the California DMV clears her after a seizure-free period; MRI only for new symptoms after a complete resectioncompletedGL-CCM-2017, GL-CA-DMV-2024, GL-AAN-FIRSTSZ-2015S

Goals

GoalTargetStatusOutcomeProvenance
EEG and MRI with susceptibility-weighted imaging within one week, and an epilepsy consultation within two weeks1996-05-05completedEEG in two days, MRI in six, consultation at two weeksS
No further seizures on an antiseizure medication she tolerates1996-10-20completedNo seizure in six months; levetiracetam tolerated after early irritability settledS
Neurosurgical evaluation of the cavernous malformation and a shared decision about lesionectomy within two months1996-07-21completedSeen by neurosurgery at three weeks; complete lesionectomy at eight weeksS
Safety plan in place: no driving until cleared, water and height safety, SUDEP discussion, and a nocturnal seizure detection plan1996-05-27completedDriving stopped and reported as California requires; SUDEP discussed (one visit late, recorded as a deviation); detection watch in useS
Graded return to full sprint training within four months of surgery1996-10-20completedFull training at four months after surgeryS

Functional Status

Mental Status